Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kwanza Price, Zhun Cao, Craig Lipkin, Deb Profant & Scott Robinson. (2022) Comparison of Hospital Length of Stay and Supportive Care Utilization Between Patients Treated with CPX-351 and 7+3 for Therapy-Related Acute Myeloid Leukemia or Acute Myeloid Leukemia with Myelodysplasia-Related Changes. ClinicoEconomics and Outcomes Research 14, pages 21-34.
Read now
Read now
George Kim, Paul Cockrum, Andy Surinach, Shu Wang & Zev Wainberg. (2022) Real-world safety and supportive care use of second-line 5-fluorouracil-based regimens among patients with metastatic pancreatic ductal adenocarcinoma. Current Medical Research and Opinion 38:8, pages 1295-1303.
Read now
Read now
Articles from other publishers (13)
Mohamedraed Elshami, Richard S. Hoehn, John B. Ammori, Jeffrey M. Hardacre, Jennifer E. Selfridge, David Bajor, Amr Mohamed, Sakti Chakrabarti, Amit Mahipal, Jordan M. Winter & Lee M. Ocuin. (2023) Disparities in guideline-compliant care for patients with pancreatic ductal adenocarcinoma at minority-versus non-minority-serving hospitals. HPB 25:12, pages 1502-1512.
Crossref
Crossref
Roberto Gonzalez, Shruthi Srinivas, Brittany L. Waterman, Mehak Chawla, Jordan M. Cloyd, Gennaro Di Tosto, Timothy M. Pawlik, Angela Sarna, Laura J. Rush, Ann Scheck McAlearney & Aslam Ejaz. (2023) Impact of early vs late palliative care referrals on healthcare utilization in patients with pancreatic cancer. Journal of Cancer Research and Clinical Oncology 149:16, pages 14997-15002.
Crossref
Crossref
Mehdi Hegagi, Paul James, Amy Hsu & Peter Tanuseputro. (2022) Home Care Use and Out-of-Hospital Death in Pancreatic Cancer Patients: A Retrospective Cohort Study. Journal of Palliative Care 38:2, pages 175-183.
Crossref
Crossref
Gentry King, Stacie Ittershagen, Luyang He, Ying Shen, Frank Li & Reginald Villacorta. (2022) Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World. Advances in Therapy 39:12, pages 5433-5452.
Crossref
Crossref
Piarella Peralta, Megan P. Hall, Seema Singh Bhan, Kim Brown, Marcus A. Parton, Krishna Yeshwant, Stephanie Finucane, Peter Keeling & Joshua J. Ofman. (2022) Industry engagement: Accelerating discovery, application, and adoption through industry partnerships. Cancer 128:S4, pages 918-926.
Crossref
Crossref
Lincoln D. Nadauld, Charles H. McDonnellIIIIII, Tomasz M. Beer, Minetta C. Liu, Eric A. Klein, Andrew Hudnut, Richard A. Whittington, Bruce Taylor, Geoffrey R. Oxnard, Jafi Lipson, Margarita Lopatin, Rita Shaknovich, Karen C. Chung, Eric T. Fung, Deborah Schrag & Catherine R. Marinac. (2021) The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice. Cancers 13:14, pages 3501.
Crossref
Crossref
Andrea BullockChristopher G. RowanNina OestreicherHoma YeganegiE. Gabriela Chiorean. (2020) Real-World Assessment of Health Care Costs for Patients with Metastatic Pancreatic Cancer Following Initiation of First-Line Chemotherapy. Journal of Managed Care & Specialty Pharmacy 26:7, pages 872-878.
Crossref
Crossref
Yunes Doleh, Lincy S. Lal, Cori Blauer‐Petersen, Giovanni Antico & Michael Pishvaian. (2020) Treatment patterns and outcomes in pancreatic cancer: Retrospective claims analysis. Cancer Medicine 9:10, pages 3463-3476.
Crossref
Crossref
Maria Pisu, Nora B. Henrikson, Matthew P. Banegas & K. Robin Yabroff. (2018) Costs of cancer along the care continuum: What we can expect based on recent literature. Cancer 124:21, pages 4181-4191.
Crossref
Crossref
Gregory A Coté, Huiping Xu, Jeffery J Easler, Timothy D Imler, Evgenia Teal, Stuart Sherman & Murray Korc. (2017) Informative Patterns of Health-Care Utilization Prior to the Diagnosis of Pancreatic Ductal Adenocarcinoma. American Journal of Epidemiology 186:8, pages 944-951.
Crossref
Crossref
Philip N. Okafor, Derrick J. Stobaugh, Augustine K. Nnadi & Jayant A. Talwalkar. (2016) Determinants of Palliative Care Utilization Among Patients Hospitalized With Metastatic Gastrointestinal Malignancies. American Journal of Hospice and Palliative Medicine® 34:3, pages 269-274.
Crossref
Crossref
Essè Ifèbi Hervé Akpo, Urbano Sbarigia, George Wan & Joris Kleintjens. (2015) Determinant Factors of the Direct Medical Costs Associated with Genotype 1 Hepatitis C Infection in Treatment-Experienced Patients. Drugs in R&D 15:4, pages 335-349.
Crossref
Crossref
Emily Nash Smyth, Bela Bapat, Daniel E. Ball, Thierry André & James A. Kaye. (2015) Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study. Clinical Therapeutics 37:6, pages 1301-1316.
Crossref
Crossref